{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:43:57Z","timestamp":1780580637870,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,9,3]],"date-time":"2013-09-03T00:00:00Z","timestamp":1378166400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/2.5"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40261-013-0126-5","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T07:23:39Z","timestamp":1378106619000},"page":"761-771","source":"Crossref","is-referenced-by-count":24,"title":["Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study"],"prefix":"10.1007","volume":"33","author":[{"given":"Rajnish","family":"Mago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Forero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Gommoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,3]]},"reference":[{"issue":"11","key":"126_CR1","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.","journal-title":"PLoS Med"},{"key":"126_CR2","unstructured":"APA practice guideline for the treatment of patients with major depressive disorder, 3rd ed. Arlington: American Psychiatric Association; 2010. http:\/\/psychiatryonline.org\/content.aspx?bookid=28&sectionid=1667485 . Accessed 19 Aug 2013."},{"issue":"4","key":"126_CR3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.31887\/DCNS.2008.10.4\/kkelly","volume":"10","author":"K Kelly","year":"2008","unstructured":"Kelly K, Posternak M, Alpert JE. Toward achieving optimal response: understanding and managing antidepressant side effects. Dialogues Clin Neurosci. 2008;10(4):409\u201318.","journal-title":"Dialogues Clin Neurosci"},{"key":"126_CR4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.neuropharm.2013.02.024","volume":"70","author":"AL Auclair","year":"2013","unstructured":"Auclair AL, Martel JC, Assi\u00e9 MB, et al. Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety. Neuropharmacology. 2013;70:338\u201347.","journal-title":"Neuropharmacology"},{"issue":"9","key":"126_CR5","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","volume":"10","author":"SM Stahl","year":"2005","unstructured":"Stahl SM, Grady MM, Moret C, et al. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr. 2005;10(9):732\u201347.","journal-title":"CNS Spectr"},{"issue":"1","key":"126_CR6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1017\/S1461145705006395","volume":"10","author":"P Blier","year":"2007","unstructured":"Blier P, Saint-Andre E, Hebert C, et al. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. Int J Neuropsychopharmacol. 2007;10(1):41\u201350.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"126_CR7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/jpet.106.103382","volume":"318","author":"DC Deecher","year":"2006","unstructured":"Deecher DC, Beyer CE, Johnston G, et al. Desvenlafaxine succinate: a new serotonin and norepinephrine reuptake inhibitor. J Pharmacol Exp Ther. 2006;318(2):657\u201365.","journal-title":"J Pharmacol Exp Ther"},{"key":"126_CR8","unstructured":"Forest Pharmaceuticals Inc. Fetzima\u00ae (levomilnacipran) extended-release capsules: U.S. Prescribing Information. St. Louis: Forest Pharmaceuticals, Inc.; 2013."},{"key":"126_CR9","unstructured":"Chen L, Boinpally R, Gad N, et al. Drug-drug interactions of levomilnacipran sustained release capsule with ketoconazole, carbamazepine, or alprazolam in healthy subjects [poster]. 166th annual American Psychiatric Association Meeting; 2013 May 18\u201322; San Francisco."},{"issue":"3","key":"126_CR10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4088\/JCP.12m08197","volume":"74","author":"G Asnis","year":"2013","unstructured":"Asnis G, Bose A, Gommoll C, et al. The efficacy and safety of levomilnacipran SR 40\u00a0mg, 80\u00a0mg, or 120\u00a0mg in major depressive disorder: a phase III, randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2013;74(3):242\u20138.","journal-title":"J Clin Psychiatry"},{"key":"126_CR11","doi-asserted-by":"crossref","unstructured":"Bakish D, Gommoll C, Chen C, et al. Levomilnacipran ER 40\u00a0mg and 80\u00a0mg in major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study Int Clin Psychopharmacol. 2013 (in press).","DOI":"10.1503\/jpn.130040"},{"issue":"4","key":"126_CR12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4088\/JCP.12m08141","volume":"74","author":"S Montgomery","year":"2013","unstructured":"Montgomery S, Mansuy L, Ruth A, et al. The efficacy and safety of levomilnacipran SR in major depressive disorder: a randomized, double-blind, placebo-controlled, proof-of-concept study. J Clin Psychiatry. 2013;74(4):363\u20139.","journal-title":"J Clin Psychiatry"},{"key":"126_CR13","unstructured":"Sambunaris A, Bose A, Gommoll C, et al. W14. A phase III, double-blind, placebo-controlled, flexible-dose study of levomilnacipran SR in patients with major depressive disorder [abstract]. Neuropsychopharmacol. 2012;38(Suppl 1):S322\u20133."},{"key":"126_CR14","unstructured":"Gommoll C, Bose A, Li H, et al. A randomized double-blind, placebo-controlled, flexible-dose study of levomilnacipran in patients with major depressive disorder [poster]. 24th Annual US Psychiatric and Mental Health Congress; 2011 Nov 7\u201310; Las Vegas."},{"key":"126_CR15","unstructured":"Shiovitz T, Bose A, Greenberg WM, et al. The efficacy and safety of levomilnacipran SR in the prevention of relapse in major depressive disorder: results from a phase III clinical trial [poster]. 25th Annual US Psychiatric and Mental Health Congress; 2012 Nov 8\u201311; San Diego."},{"key":"126_CR16","unstructured":"American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 4th ed. Text Rev. Washington, DC: American Psychiatric Association; 2000."},{"key":"126_CR17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, \u00c5sberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139.","journal-title":"Br J Psychiatry"},{"issue":"12","key":"126_CR18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","volume":"168","author":"K Posner","year":"2011","unstructured":"Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266\u201377.","journal-title":"Am J Psychiatry"},{"key":"126_CR19","unstructured":"Clinical Global Impressions. In: Guy W. ECDEU assessment manual for psychopharmacology. Rockville: National Institute of Mental Health; 1976, p. 218\u2013222. DHEW publication no. 76-338."},{"issue":"5","key":"126_CR20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/hep.22633","volume":"48","author":"PB Watkins","year":"2008","unstructured":"Watkins PB, Seligman PJ, Pears JS, Avigan MI, Senior JR. Using controlled clinical trials to learn more about acute drug-induced liver injury. Hepatology. 2008;48(5):680\u20131689.","journal-title":"Hepatology"},{"issue":"9665","key":"126_CR21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","volume":"373","author":"A Cipriani","year":"2009","unstructured":"Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 2009;373(9665):746\u201358.","journal-title":"Lancet"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-013-0126-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0126-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-013-0126-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T10:18:04Z","timestamp":1646475484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-013-0126-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,3]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["126"],"URL":"https:\/\/doi.org\/10.1007\/s40261-013-0126-5","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,3]]}}}